Male Infertility Market 2025

Male Infertility Market Size

The global male infertility market reached a value of nearly $4,103.03 million in 2024, having grown at a compound annual growth rate (CAGR) of 4.19% since 2019. The market is expected to grow from $4,103.03 million in 2024 to $5,427.76 million in 2029 at a rate of 5.76%. The market is then expected to grow at a CAGR of 5.55% from 2029 and reach $7,109.72 million in 2034. Growth in the historic period resulted from the impact of delayed parenthood, rise in medical tourism, rise in environmental and occupational hazards and rising investments in R&D and fertility biotech. Factors that negatively affected growth in the historic period were high cost of treatment and limited insurance coverage. Going forward, the growth in fertility clinics and reproductive health services, government initiatives, increasing stress levels and increasing incidence of lifestyle disorders will drive the growth. Factor that could hinder the growth of the male infertility market in the future include regulatory and ethical issues, social stigma and lack of awareness and impact of trade war and tariff.

Male Infertility Market Drivers

The key drivers of the male infertility market include: Growth In Fertility Clinics And Reproductive Health Services During forecast period, the growth in fertility clinics and reproductive health services are expected to propel the growth of the male infertility market. As awareness of male reproductive health issues increases, more individuals and couples are seeking specialized care, leading to a higher demand for diagnostic and treatment options. Fertility clinics are broadening their service offerings to include advanced male infertility solutions, such as semen analysis, hormonal testing, and sperm enhancement technologies. This growing infrastructure, combined with improved access to care and greater societal acceptance of male infertility as a medical condition, is expected to fuel market development and create new opportunities for healthcare providers and diagnostic companies. Therefore, the growth in fertility clinics and reproductive health services will drive the growth of the male infertility market. The growth in fertility clinics and reproductive health services growth contribution during the forecast period in 2024 is 1.50%.

Male Infertility Market Restraints

The key restraints on the male infertility market include: Social Stigma And Lack of Awareness During forecast period, social stigma and lack of awareness is expected to hinder the growth of the male infertility market. Many men feel embarrassment or shame when addressing fertility issues, which often leads to delays in seeking medical evaluation or treatment. Additionally, limited public education and discussion around male infertility contribute to underdiagnosis and underutilization of available services and technologies. This cultural barrier not only reduces patient engagement but also affects market penetration for companies offering male-focused fertility solutions. Addressing these challenges through awareness campaigns and education is crucial for unlocking the market’s full growth potential. Therefore, social stigma and lack of awareness may hinder the growth of the male infertility market. Growth affected by social stigma and lack of awareness during the forecast period in 2024 is -2.11%.

Male Infertility Market Trends

Major trends shaping the male infertility market include: Strategic Investments Driving Innovation In Reproductive Health Solutions Major companies operating in the male infertility market are focusing on strategic investment, to accelerate the development of novel diagnostic tools and treatments, expand their technological capabilities, and capture a larger share of the growing fertility care market. A strategic investment is an investment made by a company or organization with the primary goal of gaining long-term business benefits beyond just financial returns. For instance, in October 2024, Paterna BioSciences Inc., a US-based biotechnology company, has raised $6 million in an oversubscribed seed round led. The funding accelerates development of its pioneering in vitro spermatogenesis (IVS) technology to address male infertility, responsible for nearly 50% of failed in vitro spermatogenesis (IVS) cycles. Paterna aims to bring its fertility solution to early-phase trials in 2025, advancing reproductive care with innovative science based on a decade of research. The funding will accelerate preclinical development, infrastructure, and team growth, with early-phase studies expected in 2025. Advancing Male Infertility Diagnosis Through At-Home Fertility Test Companies operating in the male infertility market are focusing on developing at-home fertility test for gaining competitive advantage. The at-home fertility test is designed to provide an easier and faster process to traditional fertility testing, a cheaper alternative to specialist appointments and to also alleviate pressure on the National Health Service (NHS). For instance, in June 2023, Newfoundland, a UK-based company specializing in the development and distribution of diagnostic health tests launched the fastest and most affordable at-home fertility test. The new test, which is available over the counter, gives fertility results in just five minutes and boasts 98.2 per cent accuracy. The new at-home Male Fertility test will give men the opportunity to understand more about their fertility and seek the right medical advice if needed.

Opportunities And Recommendations In The Male Infertility Market

Opportunities – The top opportunities in the male infertility markets segmented by treatment type will arise in the assisted reproductive technology segment, which will gain $695.16 million of global annual sales by 2029. The top opportunities in the male infertility markets segmented by test type will arise in the deoxyribonucleic acid fragmentation technique segment, which will gain $409.37 million of global annual sales by 2029. The top opportunities in the male infertility markets segmented by end-user will arise in the fertility centers segment, which will gain $643.79 million of global annual sales by 2029. The male infertility market size will gain the most in the USA at $300.86 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the male infertility companies to focus on strategic investment to advance diagnostic and therapeutic innovation, focus on at-home fertility testing to expand access and drive differentiation, focus on assisted reproductive technology to capture high-growth market share, focus on oxidative stress analysis to maximize growth potential, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, continue to use B2B promotions, focus on strategic partnerships to broaden access and support early male fertility evaluation and focus on fertility centers to accelerate market penetration.